Agenda

1:00–2:30 p.m. ET

Meeting Welcome and Opening Plenary

Meeting Welcome from NIH
Bill Kapogiannis, M.D., NIH Office of AIDS Research

Meeting Objective and Overview
Dianne Rausch, Ph.D., NIMH Division of AIDS Research

Introduction of Opening Panel
Paul Gaist, Ph.D., NIH Office of AIDS Research

Pharmacists: Advancing Public Health
Michael D. Hogue, PharmD, FAPhA, FNAP,
American Pharmacists Association

The Role of Pharmacists in the US National HIV/AIDS Strategy
Harold Phillips, MRP, White House Office of National AIDS Policy

The US EHE Pharmacist Task Force
RDML Kelly Battese, Chief Professional Officer for Pharmacy, US Public Health Service

Pharmacies Respond to HIV
US Business Coalition to End HIV

The US Evidence Base for Pharmacy-Delivered HIV Services over the HIV Prevention and Care Continua
Natalie Crawford, Ph.D., Emory University

Lessons from Global Research in Pharmacy-Based HIV Service Delivery
Katrina Ortblad, Sc.D., Fred Hutchinson Cancer Center

Discussant Comment: Building on Our Accomplishments with Next Steps
Paul Weidle, PharmD, CDC Division of HIV Prevention

Questions for Opening Panel
Paul Gaist, Ph.D., NIH Office of AIDS Research

2:30–3:45 p.m. ET

Topic Panel One: Across the Spectrum of Community Pharmacies — From Independent to Chain

Opening Comments, Panel Introductions
Nelly Gazarian, PharmD, AAHIVP, HHS Office of Asst Secretary for Health

Community Independent Pharmacies: Furthering Innovation in Oral and Injectable PrEP Delivery
Elyse Tung, PharmD, Kelly-Ross Pharmacy

Community Chain Pharmacies: Achieving Scale and Reach
John Wigneswaran, MD, Walmart

Discussant Comments: Meeting Community Interests

Questions for the Panel
Nelly Gazarian, PharmD, AAHIVP, HHS Office of Asst Secretary for Health

3:45–5:00 p.m. ET

Topic Panel Two: Advancing HIV Testing through Pharmacies

Implementing Point of Care Testing and a Collaborative HIV Screening Program in Pharmacies
Donald G. Klepser, Ph.D., MBA, University of Nebraska Medical Center College of Pharmacy

Lessons Learned from a National HIV Testing Initiative in a Large Retail Pharmacy

AmbassADDOrs for Health: A community-randomized trial to support HIV testing and contraception access among young women through drug dispensing shops in Tanzania
Jenny Lin, Ph.D., UCSF

Considering Pharmacy Locations and Bridging "Pharmacy Deserts"
Dima Qato, PharmD, USC

Panel Questions
Michael Stirratt, Ph.D., NIMH Division of AIDS Research

Close of Day 1
Paul Gaist, Ph.D., NIH Office of AIDS Research

1:00–2:15 p.m. ET

Topic Panel Three: Advancing HIV PrEP through Pharmacies

Opening Comments, Panel Introductions
Jeremiah Johnson, PrEP4All

A Novel Community-Retail Pharmacy Partnership to Advance HIV PrEP
Mariano Kanamori, Ph.D., University of Miami Miller
School of Medicine

Nurse-facilitated PrEP delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya
Jillian Pintye, R.N., M.P.H., Ph.D., University of Washington

Understanding the implementation of SB159: Pharmacist delivered preand post-exposure prophylaxis in three high EHE counties in California
Raiza Beltran, Ph.D., UCLA

Questions for the panel
Jeremiah Johnson, PrEP4All

2:15–3:15 p.m. ET

Topic Panel Four: Advancing HIV Treatment through Pharmacies

Opening Comments, Panel Introductions
Glen Pietrandoni, RPh, AAHIVP, Avita Pharmacy 

Supporting Adherence and Viral Suppression Through the Patient-centered HIV Care Model Project: A
Collaboration Between Communitybased Pharmacists and HIV Clinical Providers
Kathy Byrd, M.D., M.P.H., CDC

Data to Care Rx: Engaging pharmacies and pharmacists in proactive efforts to retain people with HIV in care
Katrease Hale, M.P.H., Public Health Consultant
Rachel Browning, M.P.H., NASTAD

Exploring Pharmacist and Pharmacy-Based Delivery of Long-Acting Injectable ART
Jennifer Cocohoba, PharmD, UCSF

Pharmacist efforts to address social determinants of health and clinical management among people with
HIV

Questions for the panel
Glen Pietrandoni, RPh, AAHIVP, Avita Pharmacy

3:15–4:30 p.m. ET

Topic Panel Five: Addressing HIV Syndemic Factors and Co-Morbidities through Pharmacies

Improving syringe access, opioid overdose prevention, and naloxone dispensation among rural and small
metro area pharmacists
Crystal Lewis Fuller, Ph.D., New York University

A pharmacist-delivered primary care telemedicine intervention to increase access to pharmacotherapy
and specialty treatment for alcohol use problems
Stacy A. Sterling, Dr.P.H., M.S.W., M.P.H., Kaiser Permanente

Influences on the availability of medications for opioid use disorder in outpatient and inpatient pharmacies

A pharmacist-delivered intervention to address smoking cessation in people with HIV
E. Jennifer Edelman, M.D., M.H.S., Yale University

Questions for the panel

4:30–5:00 p.m. ET

Closing Session: Looking to the Future

Training Needs

Research Gaps
Walid El-Nahal, M.D., M.H.S., NIH Office of AIDS Research

Next Steps and Meeting Close